Ty S Schepis1, Brady T West2, Christian J Teter3, Sean Esteban McCabe4. 1. Department of Psychology, TX State University, USA. Electronic address: schepis@txstate.edu. 2. Center for Statistical Consultation and Research, University of MI, USA; Survey Research Center, Institute for Social Research, University of MI, USA. 3. College of Pharmacy, University of New England, USA. 4. Substance Abuse Research Center, University of MI, USA; Institute for Research on Women and Gender, University of MI, USA.
Abstract
INTRODUCTION: Nonmedical tranquilizer use (NMTU) is a concerning and understudied phenomenon in adolescents, despite being the second most prevalent form of nonmedical use in this population. Thus, this work aimed to examine the sociodemographic and substance use correlates of past-year co-ingestion of a prescription tranquilizer and another substance among adolescents. METHODS: Data were from the Monitoring the Future study, a nationally representative survey of U.S. high school students. Data from 11,444 seniors (12th graders) completing form 1 of the survey were used. The participants represented a population that was 52.7% female, 61.8% White, and had a modal age of 18. Weighted frequencies and Rao-Scott chi-square analyses were computed to describe the target population and examine associations of interest. RESULTS: An estimated 5.3% of the population engaged in past-year NMTU during this time period, with an estimated 72.6% of those users engaged in past-year co-ingestion of a tranquilizer and another substance. Marijuana and alcohol were the most commonly co-ingested substances. Those engaged in co-ingestion were more likely than past-year nonmedical users without co-ingestion to be engaged in other substance or nonmedical use (including past year nonmedical Xanax® (alprazolam) use), have an earlier onset of NMTU, and endorse recreational motives. CONCLUSIONS: Adolescent nonmedical tranquilizer users engaged in co-ingestion may be a particularly vulnerable population, with higher rates of other substance use, other nonmedical use and problematic NMTU characteristics than nonmedical users without co-ingestion. Identification of and intervention with adolescent co-ingestion users are important avenues for future research and clinical practice.
INTRODUCTION: Nonmedical tranquilizer use (NMTU) is a concerning and understudied phenomenon in adolescents, despite being the second most prevalent form of nonmedical use in this population. Thus, this work aimed to examine the sociodemographic and substance use correlates of past-year co-ingestion of a prescription tranquilizer and another substance among adolescents. METHODS: Data were from the Monitoring the Future study, a nationally representative survey of U.S. high school students. Data from 11,444 seniors (12th graders) completing form 1 of the survey were used. The participants represented a population that was 52.7% female, 61.8% White, and had a modal age of 18. Weighted frequencies and Rao-Scott chi-square analyses were computed to describe the target population and examine associations of interest. RESULTS: An estimated 5.3% of the population engaged in past-year NMTU during this time period, with an estimated 72.6% of those users engaged in past-year co-ingestion of a tranquilizer and another substance. Marijuana and alcohol were the most commonly co-ingested substances. Those engaged in co-ingestion were more likely than past-year nonmedical users without co-ingestion to be engaged in other substance or nonmedical use (including past year nonmedical Xanax® (alprazolam) use), have an earlier onset of NMTU, and endorse recreational motives. CONCLUSIONS: Adolescent nonmedical tranquilizer users engaged in co-ingestion may be a particularly vulnerable population, with higher rates of other substance use, other nonmedical use and problematic NMTU characteristics than nonmedical users without co-ingestion. Identification of and intervention with adolescent co-ingestion users are important avenues for future research and clinical practice.
Authors: Prasanthi Nattala; Kit Sang Leung; Arbi Ben Abdallah; Pratima Murthy; Linda B Cottler Journal: Am J Drug Alcohol Abuse Date: 2012-01-13 Impact factor: 3.829
Authors: Scott D Lane; Oleg V Tcheremissine; Lori M Lieving; Sylvain Nouvion; Don R Cherek Journal: Psychopharmacology (Berl) Date: 2005-04-14 Impact factor: 4.530
Authors: Laura M Garnier; Amelia M Arria; Kimberly M Caldeira; Kathryn B Vincent; Kevin E O'Grady; Eric D Wish Journal: Am J Drug Alcohol Abuse Date: 2009 Impact factor: 3.829
Authors: Alexander S Perlmutter; Ariadne E Rivera-Aguirre; Pia M Mauro; Alvaro Castillo-Carniglia; Nicolás Rodriguez; Nora Cadenas; Magdalena Cerdá; Silvia S Martins Journal: Drug Alcohol Depend Date: 2019-10-04 Impact factor: 4.492
Authors: Sean Esteban McCabe; Philip T Veliz; Kara Dickinson; Ty S Schepis; John E Schulenberg Journal: Lancet Psychiatry Date: 2019-09-11 Impact factor: 27.083
Authors: Sherry H Stewart; Annie Chinneck; Kara Thompson; Mohammad H Afzali; Raquel Nogueira-Arjona; Ioan T Mahu; Patricia J Conrod Journal: Front Psychiatry Date: 2021-04-27 Impact factor: 4.157
Authors: Jason E Goldstick; Erin E Bonar; Matthew Myers; Amy S B Bohnert; Maureen A Walton; Rebecca M Cunningham Journal: J Stud Alcohol Drugs Date: 2022-01 Impact factor: 2.582